Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eliem Therapeutics, Inc - Common Stock (NQ:ELYM)

5.110 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eliem Therapeutics, Inc - Common Stock

< Previous 1 2 3 4 Next >
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Eliem Therapeutics Announces Additions to its Leadership Team
From Eliem Therapeutics, Inc.
Via GlobeNewswire
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q2 2024
Eliem Therapeutics just reported results for the second quarter of 2024. 
Via InvestorPlace
Eliem Therapeutics Reports Second Quarter Financial Results
From Eliem Therapeutics, Inc.
Via GlobeNewswire
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
From Eliem Therapeutics, Inc.
Via GlobeNewswire
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q1 2024
Eliem Therapeutics just reported results for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Nasdaq Jumps 250 Points; Crude Oil Down 1%
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83.... 
Via Benzinga
Topics Stocks
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. 
Via Benzinga
Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal
Eliem Therapeutics will acquire Tenet Medicines, focusing on advancing TNT119, an anti-CD19 antibody for autoimmune diseases. Strategic alternatives explored. $120 million private placement.... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Dow Dips 100 Points; CarMax Earnings Miss Views
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday. 
Via Benzinga
Topics Earnings Stocks
Nasdaq Gains Over 50 Points; US Producer Prices Increase In March
U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94.... 
Via Benzinga
Topics Stocks
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
From Eliem Therapeutics, Inc.
Via GlobeNewswire
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023
Eliem Therapeutics just reported results for the fourth quarter of 2023. 
Via InvestorPlace
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
Gainers BioNexus Gene Lab Corp (NASDAQ: BGLC) shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported pricing of $5 million public offering and uplisting to the Nasdaq Capital... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
What's Happening With Eliem Therapeutics Shares Today?
Eliem Therapeutics Inc (NASDAQ: ELYM) shares are trading higher after the company completed a review of its business, including the status of its programs,  
Via Benzinga
Why Is BioSig Technologies (BSGM) Stock Up 19% Today?
BioSig Technologies (BSGM) stock is rising higher on Thursday as subsidiary BioSig AI Sciences joins Nvidia's (NVDA) Inception program. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.